TARYN GRATTIC: Open Payments
NPI 1093073926 · COEUR D ALENE, ID. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$626 in 28 payments from 11 companies in 2025. Trend: 2023 $108 · 2024 $97 · 2025 $626
Food & beverage: $626
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 9 | $206 |
| PFIZER INC. | 6 | $140 |
| Novo Nordisk Inc | 3 | $56 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $48 |
| Lilly USA, LLC | 2 | $35 |
| Alexion Pharmaceuticals, Inc. | 1 | $34 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $25 |
| Edwards Lifesciences Corporation | 1 | $24 |
| Boston Scientific Corporation | 1 | $24 |
| Exact Sciences Corporation | 1 | $19 |
Products named: UBRELVY, NURTEC ODT, CAPLYTA, PREVNAR 20, MOUNJARO, STRENSIQ, VRAYLAR, XIFAXAN.
Industry payments across ID — which companies pay providers there.
